The wordhallucinogen is derived from the wordhallucination.[5] The termhallucinate dates back to around 1595–1605, and is derived from theLatinhallūcinātus, the past participle of(h)allūcināri, meaning "to wander in the mind."[6]
Leo Hollister gave five criteria for classifying a drug as hallucinogenic.[7][8] This definition is broad enough to include a wide range of drugs and has since been shown to encompass a number of categories of drugs with different pharmacological mechanisms and behavioral effects.[8]Richard Glennon has thus given an additional two criteria that narrow the category down toclassical hallucinogens.[8] Hollister's criteria for hallucinogens were as follows:[7][8]
in proportion to other effects, changes in thought, perception, and mood should predominate;
intellectual or memory impairment should be minimal;
stupor, narcosis, or excessive stimulation should not be an integral effect;
autonomic nervous system side effects should be minimal; and
addictive craving should be absent.
Glennon's additional criteria for classical hallucinogens are that the drugs in question must also:[8]
bind at 5-HT2 serotonin receptors; and
be recognized by animals trained to discriminate the drugDOM from vehicle.
Most hallucinogens can be categorized based on their pharmacological mechanisms aspsychedelics (which areserotonergic),dissociatives (which are generally antiglutamatergic), ordeliriants (which are generallyanticholinergic).[4] However, the pharmacological mechanisms of some hallucinogens, such assalvinorin A andibogaine, do not fit into any of those categories.[4]Entactogens andcannabinoids are also sometimes considered hallucinogens.[9] Nonetheless, while the termhallucinogen is often used to refer to the broad class of drugs covered in this article, sometimes it is used to mean only classical hallucinogens (that is, psychedelics).[10] Because of this, it is important to consult the definition given in a particular source.[10] Because of the multi-facetedphenomenology brought on by hallucinogens, efforts to create standardized terminology for classifying them based on their subjective effects have not succeeded to date.[11]
Classical hallucinogens or psychedelics have been described by many names.David E. Nichols wrote in 2004:[10]
Many different names have been proposed over the years for this drug class. The famous German toxicologist Louis Lewin used the name phantastica earlier in this century, and as we shall see later, such a descriptor is not so farfetched. The most popular names—hallucinogen, psychotomimetic, and psychedelic ("mind manifesting")—have often been used interchangeably.Hallucinogen is now, however, the most common designation in the scientific literature, although it is an inaccurate descriptor of the actual effects of these drugs. In the lay press, the termpsychedelic is still the most popular and has held sway for nearly four decades. Most recently, there has been a movement in nonscientific circles to recognize the ability of these substances to provoke mystical experiences and evoke feelings of spiritual significance. Thus, the termentheogen, derived from the Greek wordentheos, which means "god within", was introduced by Ruck et al. and has seen increasing use. This term suggests that these substances reveal or allow a connection to the "divine within". Although it seems unlikely that this name will ever be accepted in formal scientific circles, its use has dramatically increased in the popular media and on internet sites. Indeed, in much of the counterculture that uses these substances, entheogen has replaced psychedelic as the name of choice and we may expect to see this trend continue.
Robin Carhart-Harris andGuy Goodwin write that the termpsychedelic is preferable tohallucinogen for describing classical psychedelics because of the termhallucinogen's "arguably misleading emphasis on these compounds' hallucinogenic properties."[12]
Certain hallucinogens aredesigner drugs, such as those in the2C and25-NB (NBOMe) families.[13] A designer drug is a structural or functional analog of a controlled substance (hallucinogenic or otherwise) that has been designed to mimic the pharmacological effects of the original drug while at the same time avoid being classified as illegal (by specification as aresearch chemical) and/or avoid detection in standard drug tests.[14]
Despite several attempts that have been made, starting in the 19th and 20th centuries, to define commonphenomenological structures (i.e., patterns of experience) brought on by classical psychedelics, a universally accepted taxonomy does not yet exist.[15][16]
A prominent element ofpsychedelic experiences is visual alteration.[15] Psychedelic visual alteration often includes spontaneous formation of complex flowing geometric visual patterning in the visual field.[16] When the eyes are open, the visual alteration is overlaid onto the objects and spaces in the physical environment; when the eyes are closed the visual alteration is seen in the "inner world" behind the eyelids.[16] These visual effects increase in complexity with higher dosages, and also when the eyes are closed.[16] The visual alteration does not normally constitutehallucinations, because the person undergoing the experience can still distinguish between real and internally generated visual phenomena, though in some cases, true hallucinations are present.[15] More rarely, psychedelic experiences can include complex hallucinations of objects, animals, people, or even whole landscapes.[15]
A number of studies byRoland R. Griffiths and other researchers have concluded that high doses ofpsilocybin and other classic psychedelics triggermystical experiences in most research participants.[17][18][19][20] Mystical experiences have been measured by a number ofpsychometric scales, including theHood Mysticism Scale, the Spiritual Transcendence Scale, and the Mystical Experience Questionnaire.[20] The revised version of the Mystical Experience Questionnaire, for example, asks participants about four dimensions of their experience, namely the "mystical" quality, positive mood such as the experience of amazement, the loss of the usual sense of time and space, and the sense that the experience cannot be adequately conveyed through words.[20] The questions on the "mystical" quality in turn probe multiple aspects: the sense of "pure" being, the sense of unity with one's surroundings, the sense that what one experienced was real, and the sense of sacredness.[20] Some researchers have questioned the interpretation of the results from these studies and whether the framework and terminology of mysticism are appropriate in a scientific context, while other researchers have responded to those criticisms and argued descriptions of mystical experiences are compatible with a scientific worldview.[21][22][23]
Link R. Swanson divides overarching scientific frameworks for understanding psychedelic experiences into two waves. In the first wave, encompassing nineteenth- and twentieth-century frameworks, he includes modelpsychosis theory (thepsychotomimetic paradigm), filtration theory, andpsychoanalytic theory.[16] In the second wave of theories, encompassing twenty-first-century frameworks, Swanson includes entropic brain theory,integrated information theory, andpredictive processing.[16] It is from the paradigm of filtration theory that the termpsychedelic derives.[16]Aldous Huxley andHumphrey Osmond applied the pre-existing ideas of filtration theory, which held that the brain filters what enters into consciousness, to explain psychedelic experiences; Huxley believed that the brain was filtering reality itself and that psychedelics granted conscious access to "Mind at Large", whereas Osmond believed that the brain was filtering aspects of the mind out of consciousness.[16] Swanson writes that Osmond's view seems "less radical, more compatible withmaterialist science, and lessepistemically andontologically committed" than Huxley's.[16]
Dissociatives produce analgesia, amnesia and catalepsy at anesthetic doses.[24] They also produce a sense of detachment from the surrounding environment, hence "the state has been designated as dissociative anesthesia since the patient truly seems disassociated from his environment."[25] Dissociative symptoms include the disruption or compartmentalization of "...the usually integrated functions of consciousness, memory, identity or perception."[26]p. 523 Dissociation of sensory input can causederealization, the perception of the outside world as being dream-like, vague or unreal. Other dissociative experiences includedepersonalization, which includes feeling dissociated from one's personality; feeling unreal; feeling able to observe one's actions but not actively take control; being unable to associate with one's self in the mirror while maintaining rational awareness that the image in the mirror is the same person.[27] In a 2004 paper, Daphne Simeon offered "...common descriptions of depersonalisation experiences: watching oneself from a distance (similar to watching a movie); candidout-of-body experiences; a sense of just going through the motions; one part of the self acting/participating while the other part is observing;...."[28]
Some dissociatives can haveCNSdepressant effects, thereby carrying similar risks asopioids, which can slow breathing or heart rate to levels resulting in death (when using very high doses). DXM in higher doses can increase heart rate and blood pressure and still depress respiration. Inversely, PCP can have more unpredictable effects and has often been classified as a stimulant and a depressant in some texts along with being as a dissociative. While many have reported that they "feel no pain" while under the effects of PCP, DXM and Ketamine, this does not fall under the usual classification of anesthetics in recreational doses (anesthetic doses of DXM may be dangerous). Rather, true to their name, they process pain as a kind of "far away" sensation; pain, although present, becomes a disembodied experience and there is much less emotion associated with it. As for probably the most common dissociative,nitrous oxide, the principal risk seems to be due tooxygen deprivation. Injury from falling is also a danger, as nitrous oxide may cause sudden loss of consciousness, an effect of oxygen deprivation. Because of the high level of physical activity and relative imperviousness to pain induced by PCP, some deaths have been reported due to the release of myoglobin from ruptured muscle cells. High amounts of myoglobin can inducerenal shutdown.[33]
Many users of dissociatives have been concerned about the possibility of NMDA antagonistneurotoxicity (NAN). This concern is partly due to William E. White, the author of theDXM FAQ, who claimed that dissociatives definitely cause brain damage.[34] The argument was criticized on the basis of lack of evidence[35] and White retracted his claim.[36] White's claims and the ensuing criticism surrounded original research byJohn Olney.
In 1989,John Olney discovered that neuronal vacuolation and other cytotoxic changes ("lesions") occurred in brains of rats administered NMDA antagonists, includingPCP andketamine.[37] Repeated doses of NMDA antagonists led to cellular tolerance and hence continuous exposure to NMDA antagonists did not lead to cumulative neurotoxic effects. Antihistamines such as diphenhydramine, barbiturates and even diazepam have been found to prevent NAN.[38]LSD andDOB have also been found to prevent NAN.[39]
Deliriants, as their name implies, induce a state ofdelirium in the user, characterized by extreme confusion and an inability to control one's actions. They are called deliriants because their subjective effects are similar to the experiences of people with delirious fevers. The term was introduced byDavid F. Duncan andRobert S. Gold to distinguish these drugs frompsychedelics anddissociatives, such asLSD andketamine respectively, due to their primary effect of causing delirium, as opposed to the more lucid states produced by the other hallucinogens.[40][page needed]
Despite the fully legal status of several common deliriant plants, deliriants are largely unpopular asrecreational drugs due to the severe, generally unpleasant and often dangerous nature of the hallucinogenic effects produced.[41][page needed]
Historically, hallucinogens have been commonly used in religious orshamanicrituals. In this context they are referred to asentheogens, and are used to facilitate healing, divination, communication with spirits, and coming-of-age ceremonies.[51] Evidence exists for the use of entheogens inprehistoric times, as well as in numerous ancient cultures, includingAncient Egyptian,Mycenaean,Ancient Greek,Vedic,Maya,Inca andAztec cultures. TheUpper Amazon is home to the strongest extant entheogenic tradition; theUrarina of thePeruvian Amazon, for instance, continue to practice an elaborate system ofayahuasca shamanism, coupled with ananimistic belief system.[52]
Shamans consume hallucinogenic substances in order to induce a trance. Once in this trance, shamans believe that they are able to communicate with the spirit world, and can see what is causing their patients' illness. The Aguaruna of Peru believe that many illnesses are caused by the darts of sorcerers. Under the influence ofyaji, a hallucinogenic drink, Aguaruna shamans try to discover and remove the darts from their patients.[53]
In the 1970s, Frida G. Surawicz and Richard Banta published a review of two case studies where hallucinogenic drug use appeared to play a role in "delusions of being changed into a wolf" (sometimes referred to as "lycanthropy," or being a "werewolf"). They described a patient whose delusion was thought to be caused by an altered state of consciousness "brought on by LSD and strychnine and continued casual marijuana use." The review was published in the Canadian Psychiatric Association Journal. While both central cases described white male patients from contemporary Appalachia, Surawicz and Banta generalized their conclusions about a link between hallucinogens and "lycanthropy," based on historical accounts that reference myriad types of pharmacologically-similar drug-use alongside descriptions of "lycanthropes."[54]
In an 1860 book, the mycologistMordecai Cubitt Cooke differentiated a class of drugs roughly corresponding to hallucinogens fromopiates, and in 1924 the toxicologist Louis Lewin described hallucinogens in depth under the namephantastica. From the 1920s on, work inpsychopharmacology andethnobotany resulted in more detailed knowledge of various hallucinogens. In 1943,Albert Hofmann discovered the hallucinogenic properties oflysergic acid diethylamide (LSD), which raised the prospect of hallucinogens becoming more broadly available.[55]
After World War II there was an explosion of interest in hallucinogenic drugs inpsychiatry, owing mainly to the invention of LSD. Interest in the drugs tended to focus on either the potential forpsychotherapeutic applications of the drugs (seepsychedelic psychotherapy), or on the use of hallucinogens to produce a "controlledpsychosis", in order to understand psychotic disorders such asschizophrenia. By 1951, more than 100 articles on LSD had appeared in medical journals, and by 1961, the number had increased to more than 1,000 articles.[56]
At the beginning of the 1950s, the existence of hallucinogenic drugs was virtually unknown to the general public in theWest. However this soon changed as several influential figures were introduced to the hallucinogenic experience.Aldous Huxley's 1953 essayThe Doors of Perception, describing his experiences withmescaline, andR. Gordon Wasson's 1957Life magazine article ("Seeking the Magic Mushroom") brought the topic into the public limelight. In the early 1960s,counterculture icons such asJerry Garcia,Timothy Leary,Allen Ginsberg andKen Kesey advocated the drugs for theirpsychedelic effects, and a largesubculture of psychedelic drug users was spawned. Psychedelic drugs played a major role in catalyzing the major social changes initiated in the 1960s.[57][58] As a result of the growing popularity of LSD and disdain for thehippies with whom it was heavily associated, LSD was banned in the United States in 1967.[59] This greatly reduced the clinical research about LSD, although limited experiments continued to take place, such as those conducted by Reese Jones in San Francisco.[60]
As early as the 1960s, research into the medicinal properties of LSD was being conducted. According to pharmacologistDavid E. Nichols, "Savage et al. (1962) provided the earliest report of efficacy for a hallucinogen in OCD, where after two doses of LSD, a patient who suffered from depression and violent obsessive sexual thoughts experienced dramatic and permanent improvement".[10]
Starting in the mid-20th century, psychedelic drugs have received extensive attention in the Western world. They have been and are being explored as potential therapeutic agents in treatingalcoholism,[61] and other forms of drugaddiction.[62][63][64]
In the U.S., classical hallucinogens (psychedelics) are in the most strictly prohibited class of drugs, known as Schedule 1 drugs.[10] This classification was created for drugs that meet the three following characteristics: 1) they have no currently accepted medical use, 2) there is a lack of safety for their use under medical supervision, and 3) they have a high potential for abuse.[10] However, pharmacologist David E. Nichols argues that hallucinogens were placed in this class for political rather than scientific reasons.[10] In 2006,Albert Hofmann, the chemist who discovered LSD, said he believed LSD could be valuable when used in a medical rather than recreational context, and said it should be regulated in the same way asmorphine rather than more strictly.[65]
TheNetherlands previously allowedpsilocybin mushrooms to be sold, but in October 2007 the Dutch government moved to ban their sale following several widely publicized incidents involving tourists.[66] In November 2020,Oregon became the first U.S. state to bothdecriminalize psilocybin and legalize it for therapeutic use, afterBallot Measure 109 passed.[67]
No clear connection has been made between psychedelic drugs and organic brain damage. However,hallucinogen persisting perception disorder (HPPD) is a diagnosed condition wherein certain visual effects of drugs persist for a long time, sometimes permanently,[68] although the underlying cause and pathology remains unclear.[69]
A large epidemiological study in the U.S. found that other than personality disorders and other substance use disorders, lifetime hallucinogen use was not associated with other mental disorders, and that risk of developing a hallucinogen use disorder was very low.[70]
A 2019 systematic review and meta-analysis by Murrie et al. found that the transition rate from a diagnosis of hallucinogen-inducedpsychosis to that ofschizophrenia was 26% (CI 14%-43%), which was lower than cannabis-induced psychosis (34%) but higher than amphetamine (22%), opioid (12%),alcohol (10%) andsedative (9%) induced psychoses. Transition rates were not affected by sex, country of the study, hospital or community location, urban or rural setting, diagnostic methods, or duration of follow-up. In comparison, the transition rate for brief, atypical and not otherwise specified psychosis was found to be 36%.[71]
LSD, mescaline, psilocybin, and PCP are drugs that cause hallucinations, which can alter a person's perception of reality. LSD, mescaline, and psilocybin cause their effects by initially disrupting the interaction of nerve cells and the neurotransmitter serotonin.[74] It is distributed throughout the brain and spinal cord, where the serotonin system is involved with controlling of the behavioral, perceptual, and regulatory systems. This also includes mood, hunger, body temperature, sexual behavior, muscle control, and sensory perception. Certain hallucinogens, such as PCP, act through a glutamate receptor in the brain which is important for perception of pain, responses to the environment, and learning and memory.Thus far, there have been no properly controlled research studies on the specific effects of these drugs on the human brain, but smaller studies have shown some of the documented effects associated with the use of hallucinogens.[74]
While early researchers believed certain hallucinogens mimicked the effects of schizophrenia, it has since been discovered that some hallucinogens resemble endogenous psychoses more than others. PCP and ketamine more closely resemble endogenous psychoses because they reproduce both positive and negative symptoms of psychoses, while psilocybin and related hallucinogens typically produce effects resembling only the positive symptoms of schizophrenia.[75] While the serotonergic psychedelics (LSD, psilocybin, mescaline, etc.) do produce subjective effects distinct from NMDA antagonist dissociatives (PCP, ketamine, dextrorphan), there is clear overlap in the mental processes that these drugs affect and research has discovered that there is overlap in the mechanisms by which both these types of hallucinogens mimic psychotic symptoms.[76][77][78] One double-blind study examining the differences betweenDMT andketamine hypothesized thatclassically psychedelic drugs most resembleparanoid schizophrenia whiledissociative drugs best mimicked catatonic subtypes or otherwise undifferentiated schizophrenia.[79] The researchers stated that their findings supported the view that "a heterogeneous disorder like schizophrenia is unlikely to be modeled accurately by a single pharmacological agent."[79]
Classical hallucinogens (psychedelics) can be divided into three main chemical classes: tryptamines (such aspsilocin andDMT), ergolines (such asLSD), and phenethylamines (such asmescaline).[72] Tryptamines closely resembleserotonin chemically.[72]
^abcdeVolgin, Andrey D.; Yakovlev, Oleg A.; Demin, Constantin A.; Alekseeva, Polina A.; Kyzar, Evan J.; Collins, Christopher; Nichols, David E.; Kalueff, Allan V. (2019). "Understanding Central Nervous System Effects of Deliriant Hallucinogenic Drugs through Experimental Animal Models".ACS Chemical Neuroscience.10 (1):143–154.doi:10.1021/acschemneuro.8b00433.PMID30252437.S2CID52824516.
^abGlennon RA. Classical drugs: an introductory overview. In Lin GC and Glennon RA (eds).Hallucinogens: an updateArchived 23 July 2015 at theWayback Machine. National Institute on Drug Abuse: Rockville, MD, 1994.
^Hermle, Leo; Kraehenmann, Rainer (2017).Experimental Psychosis Research and Schizophrenia—Similarities and Dissimilarities in Psychopathology. Current Topics in Behavioral Neurosciences. Vol. 36. pp. 313–332.doi:10.1007/7854_2016_460.ISBN978-3-662-55878-2.PMID28444578.
^Wohlfarth A, Weinmann W (May 2010). "Bioanalysis of new designer drugs".Bioanalysis.2 (5):965–79.doi:10.4155/bio.10.32.PMID21083227.
^abcdPreller, Katrin H.; Vollenweider, Franz X. (2016). "Phenomenology, Structure, and Dynamic of Psychedelic States". In Adam L. Halberstadt; Franz X. Vollenweider; David E. Nichols (eds.).Behavioral Neurobiology of Psychedelic Drugs. Current Topics in Behavioral Neurosciences. Vol. 36. Berlin, Heidelberg: Springer Berlin Heidelberg. pp. 221–256.doi:10.1007/7854_2016_459.ISBN978-3-662-55878-2.PMID28025814.
^R. R. Griffiths; W. A. Richards; U. McCann; R. Jesse (7 July 2006). "Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance".Psychopharmacology.187 (3):268–283.doi:10.1007/s00213-006-0457-5.PMID16826400.S2CID7845214.
^abcdJohnson, Matthew W.; Hendricks, Peter S.; Barrett, Frederick S.; Griffiths, Roland R. (2019). "Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function".Pharmacology & Therapeutics.197:83–102.doi:10.1016/j.pharmthera.2018.11.010.PMID30521880.S2CID54467870.
^Pender JW (October 1972)."Dissociative anesthesia".California Medicine Some Dissociatives Have General Depressant Effects as Well, Which is Why Doctors Prescribe Them to Sedate Patients Who Are in Pain or to Help Maintain General Anesthesia During an Operation. Common Dissociative Drugs Include: PCP (Phencyclidine).117 (4):46–7.PMC1518731.PMID18730832.
^American Psychiatric Association. Diagnostic and statistical manual of mental disorders (4th ed., text revision). Washington, DC: American Psychiatric Association, 2000.
^Simeon D, Gross S, Guralnik O, Stein DJ, Schmeidler J, Hollander E (August 1997). "Feeling unreal: 30 cases of DSM-III-R depersonalization disorder".The American Journal of Psychiatry.154 (8):1107–13.doi:10.1176/ajp.154.8.1107.PMID9247397.S2CID10128404.
^Herling S, Coale EH, Hein DW, Winger G, Woods JH (1981). "Similarity of the discriminative stimulus effects of ketamine, cyclazocine, and dextrorphan in the pigeon".Psychopharmacology.73 (3):286–91.doi:10.1007/BF00422419.hdl:2027.42/46423.PMID6787651.S2CID2369250.
^Nicholson KL, Hayes BA, Balster RL (September 1999). "Evaluation of the reinforcing properties and phencyclidine-like discriminative stimulus effects of dextromethorphan and dextrorphan in rats and rhesus monkeys".Psychopharmacology.146 (1):49–59.doi:10.1007/s002130051087.PMID10485964.S2CID28576850.
^Price, William A.; Giannini, Matthew C.; Giannini, A. James (1984). "Antidotal Strategies in Phencyclidine Intoxication".The International Journal of Psychiatry in Medicine.14 (4):315–21.doi:10.2190/KKAW-PWGF-W7RQ-23GN.S2CID72401949.
^Schultes, Richard Evans; Hofmann, Albert (1979). The Botany and Chemistry of Hallucinogens (2nd ed.). Springfield Illinois: Charles C. Thomas.
^Emboden, William, Narcotic Plants – Hallucinogens, stimulants, inebriants, and hypnotics, their origins and uses 2nd edition, revised and enlarged, pub. Macmillan Publishing Co., Inc., New York 1979,ISBN0-02-535480-9.
^Beaver, Kathleen M; Gavin, Thomas J (1998). "Treatment of acute anticholinergic poisoning with physostigmine".The American Journal of Emergency Medicine.16 (5):505–507.doi:10.1016/S0735-6757(98)90003-1.PMID9725967.
^Domnauer C, Dentinger B (24 May 2022).Reports of Psychoactive Bolete Mushrooms. ESPD55 (Ethnopharmacologic Search for Psychoactive Drugs 55). McKenna Academy of Natural Philosophy.
^Blom JD (June 2021). "Leroy's elusive little people: A systematic review on lilliputian hallucinations".Neurosci Biobehav Rev.125:627–636.doi:10.1016/j.neubiorev.2021.03.002.PMID33676962.
^Brimblecombe RW, Pinder RM (1975). "Phenylalkylamines and Their Derivatives".Hallucinogenic Agents. Bristol: Wright-Scientechnica. pp. 55–97. Archived fromthe original on 27 May 2025. Retrieved31 May 2025.
^Goffman, Ken (2004).Counterculture through the Ages: From Abraham to Acid House. New York: Villard. Chapters 11–13.ISBN978-0-8129-7475-1.
^Lindsey, Brink (2007).The Age of Abundance: How Prosperity Transformed America's Politics and Culture. New York: Collins. p. 156....pot and psychedelics revealed to their users wildly different visions of reality from the "straight" one everybody took for granted. ... Guided into those transcendent realms, many young and impressionable minds were set aflame with visions of radical change. ... Antiwar protesters, feminists, student rebels, environmentalists, and gays all took their turns marching to the solemn strains of "We Shall Overcome"...
^Goffman, Ken (2004).Counterculture through the Ages: From Abraham to Acid House. New York: Villard. pp. 266–267.ISBN978-0-8129-7475-1.By normative social standards, something unseemly was going on, but since LSD, the catalyst that was unleashing the celebratory chaos, was still legal [in 1966], there was little [the authorities] could do... [That year, a]cross the nation, states started passing laws prohibiting LSD. .... By their panic, as expressed through their prohibitionary legislation, the conservative forces teased out what was perhaps the central countercultural progression for this epoch.
^Francom P, Andrenyak D, Lim HK, Bridges RR, Foltz RL, Jones RT (January–February 1988). "Determination of LSD in urine by capillary column gas chromatography and electron impact mass spectrometry".Journal of Analytical Toxicology.12 (1):1–8.doi:10.1093/jat/12.1.1.PMID3352236.
^Halpern, John H.; Lerner, Arturo G.; Passie, Torsten (2018). "A Review of Hallucinogen Persisting Perception Disorder (HPPD) and an Exploratory Study of Subjects Claiming Symptoms of HPPD".Behavioral Neurobiology of Psychedelic Drugs. Current Topics in Behavioral Neurosciences.36:333–360.doi:10.1007/7854_2016_457.ISBN978-3-662-55878-2.PMID27822679.
^Shalit N, Rehm J, Lev-Ran S (2019). "Epidemiology of hallucinogen use in the U.S. results from the National epidemiologic survey on alcohol and related conditions III".Addictive Behaviors.89:35–43.doi:10.1016/j.addbeh.2018.09.020.PMID30245407.S2CID52821352.
^abcdNichols, David E. (2018), Halberstadt, Adam L.; Vollenweider, Franz X.; Nichols, David E. (eds.), "Chemistry and Structure–Activity Relationships of Psychedelics",Behavioral Neurobiology of Psychedelic Drugs, Current Topics in Behavioral Neurosciences, vol. 36, Berlin, Heidelberg: Springer, pp. 1–43,doi:10.1007/7854_2017_475,ISBN978-3-662-55880-5,PMID28401524
^Vollenweider FX, Geyer MA (November 2001). "A systems model of altered consciousness: integrating natural and drug-induced psychoses".Brain Research Bulletin.56 (5):495–507.doi:10.1016/S0361-9230(01)00646-3.PMID11750795.S2CID230298.
^Svenningsson P, Tzavara ET, Carruthers R, Rachleff I, Wattler S, Nehls M, McKinzie DL, Fienberg AA, Nomikos GG, Greengard P (November 2003). "Diverse psychotomimetics act through a common signaling pathway".Science.302 (5649):1412–5.Bibcode:2003Sci...302.1412S.doi:10.1126/science.1089681.PMID14631045.S2CID84901005.
^abGouzoulis-Mayfrank E, Heekeren K, Neukirch A, Stoll M, Stock C, Obradovic M, Kovar KA (November 2005). "Psychological effects of (S)-ketamine and N,N-dimethyltryptamine (DMT): a double-blind, cross-over study in healthy volunteers".Pharmacopsychiatry.38 (6):301–11.doi:10.1055/s-2005-916185.PMID16342002.S2CID28653940.
Ann & Alexander Shulgin: PIHKAL (Phenethylamines I Have Known And Loved), a Chemical Love Story
Ann & Alexander Shulgin: TIHKAL (Tryptamines I Have Known And Loved), the Continuation
Charles S. Grob, ed.: Hallucinogens, a reader
Winkelman, Michael J., and Thomas B. Roberts (editors) (2007).Psychedelic Medicine: New Evidence for Hallucinogens as Treatments 2 Volumes. Westport, CT: Praeger/Greenwood.